Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus

Virus Research

Volumn 107, Issue 2, 2005, Pages 183-193

  Pariente, Nonia ^a,b   Sierra, Saleta ^a   Airaksinen, Antero ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PL 210 FI 00531 Helsinki Finland   (Finland)

Author keywords

5 azacytidine; Error catastrophe; Fluorouracil; FMDV; Foot and mouth disease virus; Inhibitor; Lethal mutagenesis; Mutagen; Mycophenolic acid; Picornavirus; Ribavirin; Viral extinction

Indexed keywords

ANTIVIRUS AGENT; AZACITIDINE; FLUOROURACIL; GUANIDINE; GUANOSINE TRIPHOSPHATE; HEPARIN; MYCOPHENOLIC ACID; RIBAVIRIN;

CELL CULTURE; CYTOLYSIS; DRUG MECHANISM; ERADICATION THERAPY; FOOT AND MOUTH DISEASE VIRUS; MOLECULAR DYNAMICS; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; REVIEW; SPECIES EXTINCTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS MUTATION;

FOOT-AND-MOUTH DISEASE VIRUS; PICORNAVIRIDAE;

EID: 11844257643     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.11.008     Document Type: Article

References (94)

1. A. Airaksinen, N. Pariente, L. Menéndez-Arias, and E. Domingo Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis Virology 311 2003 339 349
2. H.L. Bachrach Foot-and-mouth disease virus Annu. Rev. Microbiol. 22 1968 201 244
3. E. Baranowski, C.M. Ruiz-Jarabo, and E. Domingo Evolution of cell recognition by viruses Science 292 2001 1102 1105
4. E. Baranowski, C.M. Ruiz-Jarabo, N. Pariente, and E. Domingo Evolution of cell recognition by viruses: a source of biological novelty with medical implications Adv. Virus Res. 62 2003 19 111
5. E. Baranowski, C.M. Ruíz-Jarabo, N. Sevilla, D. Andreu, E. Beck, and E. Domingo Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage J. Virol. 74 4 2000 1641 1647
6. E. Baranowski, N. Sevilla, N. Verdaguer, C.M. Ruíz-Jarabo, E. Beck, and E. Domingo Multiple virulence determinants of foot-and-mouth disease virus in cell culture J. Virol. 72 8 1998 6362 6372
7. C. Barsotti, and P.L. Ipata Pathways for alpha-D-ribose utilization for nucleobase salvage and 5-fluorouracil activation in rat brain Biochem. Pharmacol. 63 2 2002 117 122
8. D.N. Black, and F. Brown Effect of actinomycin D and guanidine on the formation of a ribonucleic acid polymerase induced by foot-and-mouth disease virus and on the replication of virus and viral ribonucleic acid Biochem. J. 112 3 1969 317 323
9. N. Charpentier, M. Dávila, E. Domingo, and C. Escarmís Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene Virology 223 1 1996 10 18
10. A. Cihak, J. Vesely, and F. Sorm Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine Biochim. Biophys. Acta 108 3 1965 516 518
11. J.M. Coffin HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 267 5197 1995 483 489
12. H.E. Conrad Heparin-Binding Proteins 1998 Academic Press San Diego
13. A.M. Contreras, Y. Hiasa, W. He, A. Terella, E.V. Schmidt, and R.T. Chung Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system J. Virol. 76 17 2002 8505 8517
14. Correa Melo, E., Lopez, A., 2002. Control of foot and mouth disease: the experience of the Americas. Rev. Sci. Tech. 21 (3), 695-698, 689-694.
15. E. Correa Melo, V. Saraiva, and V. Astudillo Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication Rev. Sci. Tech. 21 3 2002 429 436
16. S. Crotty, C. Cameron, and R. Andino Ribavirin's antiviral mechanism of action: lethal mutagenesis? J. Mol. Med. 80 2 2002 86 95
17. S. Crotty, C.E. Cameron, and R. Andino RNA virus error catastrophe: direct molecular test by using ribavirin Proc. Natl. Acad. Sci. U.S.A. 98 12 2001 6895 6900
18. S. Crotty, D. Maag, J.J. Arnold, W. Zhong, J.Y. Lau, Z. Hong, R. Andino, and C.E. Cameron The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen Nat. Med. 6 12 2000 1375 1379
19. W.O. Dawson Guanidine inhibits tobacco mosaic virus RNA synthesis at two stages Intervirology 6 2 1975 83 89
20. J.C. de la Torre, B. Alarcón, E. Martínez-Salas, L. Carrasco, and E. Domingo Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro J. Virol. 61 1 1987 233 235
21. J.C. de la Torre, M. Dávila, F. Sobrino, J. Ortín, and E. Domingo Establishment of cell lines persistently infected with foot-and-mouth disease virus Virology 145 1 1985 24 35
22. J.C. de la Torre, S. de la Luna, J. Diez, and E. Domingo Resistance to foot-and-mouth disease virus mediated by trans-acting cellular products J. Virol. 63 5 1989 2385 2387
23. J.C. de la Torre, and E. Domingo Minimum number of cells required for reconstitution of a foot-and-mouth disease virus-carrier cell culture Microbiologia 4 3 1988 161 166
24. J.C. de la Torre, E. Martínez-Salas, J. Díez, and E. Domingo Extensive cell heterogeneity during persistent infection with foot-and-mouth disease virus J. Virol. 63 1 1989 59 63
25. J.C. de la Torre, E. Martínez-Salas, J. Díez, A. Villaverde, F. Gebauer, E. Rocha, M. Dávila, and E. Domingo Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture J. Virol. 62 6 1988 2050 2058
26. J.C. de la Torre, E. Wimmer, and J.J. Holland Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus J. Virol. 64 2 1990 664 671
27. T.M. Devlin fifth ed. T.M. Devlin Biochemistry with Clinical Correlations 2002 Wiley-Liss New York
28. J. Díez, M. Dávila, C. Escarmís, M.G. Mateu, J. Domínguez, J.J. Pérez, E. Giralt, J.A. Melero, and E. Domingo Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture J. Virol. 64 11 1990 5519 5528
29. E. Domingo Quasispecies and the development of new antiviral strategies Prog. Drug Res. 60 2003 133 158
30. E. Domingo, C.K. Biebricher, J.J. Holland, and M. Eigen Quasispecies and RNA Virus Evolution: Principles and Consequences 2001 Landes Bioscience Austin, Texas
31. E. Domingo, C. Escarmís, E. Baranowski, C.M. Ruiz-Jarabo, E. Carrillo, J.I. Nuñez, and F. Sobrino Evolution of foot-and-mouth disease virus Virus Res. 91 2003 47 63
32. E. Domingo, C. Escarmis, M.A. Martinez, E. Martinez-Salas, and M.G. Mateu Foot-and-mouth disease virus populations are quasispecies Curr. Top. Microbiol. Immunol. 176 1992 33 47
33. E. Domingo, and J.J. Holland Mutation rates and rapid evolution of RNA viruses S.S. Morse Evolutionary Biology of Viruses 1994 Raven Press New York 161 184
34. M. Dragun, B. Rada, L. Novotny, and J. Beranek Antiviral activities of pyrimidine nucleoside analogues: some structure-activity relationships Acta Virol. 34 4 1990 321 329
35. J.W. Drake, and J.J. Holland Mutation rates among RNA viruses Proc. Natl. Acad. Sci. U.S.A. 96 1999 13910 13913
36. M. Eigen Error catastrophe and antiviral strategy Proc. Natl. Acad. Sci. U.S.A. 99 21 2002 13374 13376
37. M. Eigen, and C.K. Biebricher Sequence space and quasispecies distribution E. Domingo P. Ahlquist J.J. Holland RNA Genetics vol. 3 1988 CRC Press Boca Raton, FL 211 245
38. M. Eigen, J. McCaskill, and P. Schuster Molecular quasi-species J. Phys. Chem. 92 1988 6881 6891
39. C. Escarmis, M. Dávila, N. Charpentier, A. Bracho, A. Moya, and E. Domingo Genetic lesions associated with Muller's ratchet in an RNA virus J. Mol. Biol. 264 1996 255 267
40. C. Escarmis, M. Dávila, and E. Domingo Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet J. Mol. Biol. 285 2 1999 495 505
41. C. Escarmis, G. Gómez-Mariano, M. Dávila, E. Lázaro, and E. Domingo Resistance to extinction of low fitness virus subjected to plaque-to-plaque transfers: diversification by mutation clustering J. Mol. Biol. 315 4 2002 647 661
42. X. Forns, R.H. Purcell, and J. Bukh Quasispecies in viral persistence and pathogenesis of hepatitis C virus Trends Microbiol. 7 1999 402 410
43. T.J. Franklin, and J.M. Cook The inhibition of nucleic acid synthesis by mycophenolic acid Biochem. J. 113 3 1969 515 524
44. R.M. Friedman Basis for variable response of arboviruses to guanidine treatment J. Virol. 6 5 1970 628 636
45. C. Gonzalez-Lopez, A. Arias, N. Pariente, G. Gómez-Mariano, and E. Domingo Preextinction RNA can interfere with infectivity J. Virol. 78 2004 3319 3324
46. M.P. Gordon, and M. Staehelin Studies on the incorporation of 5-fluorouracil into a virus nucleic acid Biochim. Biophys. Acta 36 1959 351 361
47. A. Grande-Perez, S. Sierra, M.G. Castro, E. Domingo, and P.R. Lowenstein From the cover: molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity Proc. Natl. Acad. Sci. U.S.A. 99 20 2002 12938 12943
48. S.M. Hammer, K.E. Squires, M.D. Hughes, J.M. Grimes, L.M. Demeter, J.S. Currier, J.J. Eron Jr., J.E. Feinberg, H.H. Balfour Jr., L.R. Deyton, J.A. Chodakewitz, and M.A. Fischl A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team N. Engl. J. Med. 337 11 1997 725 733
49. D.D. Ho Time to hit HIV, early and hard N. Engl. J. Med. 333 7 1995 450 451
50. D.D. Ho Toward HIV eradication or remission: the tasks ahead Science 280 5371 1998 1866 1867
51. J.J. Holland, E. Domingo, J.C. de la Torre, and D.A. Steinhauer Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis J. Virol. 64 8 1990 3960 3962
52. P.A. Jones, and S.M. Taylor Cellular differentiation, cytidine analogs and DNA methylation Cell 20 1 1980 85 93
53. R.E. Lanford, D. Chavez, B. Guerra, J.Y. Lau, Z. Hong, K.M. Brasky, and B. Beames Ribavirin induces error-prone replication of gb virus b in primary tamarin hepatocytes J. Virol. 75 17 2001 8074 8081
54. R.S. Lasken, and M.F. Goodman The biochemical basis of 5-bromouracil-induced mutagenesis. Heteroduplex base mispairs involving bromouracil in G × C → A × T and A × T → G × C mutational pathways J. Biol. Chem. 259 18 1984 11491 11495
55. C.H. Lee, D.L. Gilbertson, I.S. Novella, R. Huerta, E. Domingo, and J.J. Holland Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus J. Virol. 71 5 1997 3636 3640
56. H.J. Lee, K. Pawlak, B.T. Nguyen, R.K. Robins, and W. Sadee Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture Cancer Res. 45 11 Pt 1 1985 5512 5520
57. L.A. Loeb, J.M. Essigmann, F. Kazazi, J. Zhang, K.D. Rose, and J.I. Mullins Lethal mutagenesis of HIV with mutagenic nucleoside analogs Proc. Natl. Acad. Sci. U.S.A. 96 1999 1492 1497
58. L.A. Loeb, and J.I. Mullins Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs AIDS Res. Hum. Retroviruses 13 2000 1 3
59. J.K. Lowe, L. Brox, and J.F. Henderson Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole Cancer Res. 37 3 1977 736 743
60. D. Maag, C. Castro, Z. Hong, and C.E. Cameron Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin J. Biol. Chem. 276 49 2001 46094 46098
61. L.M. Mansky, and L.C. Bernard 3′-Azido-3′-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1 J. Virol. 74 20 2000 9532 9539
62. M.A. Martinez, N. Verdaguer, M.G. Mateu, and E. Domingo Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus Proc. Natl. Acad. Sci. U.S.A. 94 13 1997 6798 6802
63. R.E. Notari, and J.L. DeYoung Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions J. Pharm. Sci. 64 7 1975 1148 1157
64. I.S. Novella, C.L. Hershey, C. Escarmis, E. Domingo, and J.J. Holland Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells J. Mol. Biol. 287 3 1999 459 465
65. N. Pariente, A. Airaksinen, and E. Domingo Comparison of mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus J. Virol. 77 12 2003 7131 7138
66. N. Pariente, S. Sierra, P.R. Lowenstein, and E. Domingo Efficient virus extinction by combinations of a mutagen and antiviral inhibitors J. Virol. 75 20 2001 9723 9730
67. W.B. Parker, and Y.C. Cheng Metabolism and mechanism of action of 5-fluorouracil Pharmacol. Ther. 48 3 1990 381 395
68. J.K. Pfeiffer, and K. Kirkegaard A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity Proc. Natl. Acad. Sci. U.S.A. 100 12 2003 7289 7294
69. T. Pfister, and E. Wimmer Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication J. Biol. Chem. 274 11 1999 6992 7001
70. P.G. Plagemann, M. Behrens, and D. Abraham Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin Cancer Res. 38 8 1978 2458 2466
71. W.A. Righstel, J.R. Dice, R.J. McAlpine, E.A. Timm, I.W.J. McLean, G.J. Dixon, and F.M.J. Schabel Antiviral effect of guanidine Science 134 1961 558 559
72. C.M. Ruiz-Jarabo, A. Arias, C. Molina-Paris, C. Briones, E. Baranowski, C. Escarmis, and E. Domingo Duration and fitness dependence of quasispecies memory J. Mol. Biol. 315 3 2002 285 296
73. C.M. Ruiz-Jarabo, C. Ly, E. Domingo, and J.C. de la Torre Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) Virology 308 1 2003 37 47
74. C.M. Ruiz-Jarabo, N. Pariente, E. Baranowski, M. Dávila, G. Gómez-Mariano, and E. Domingo Expansion of host-cell tropism of foot-and-mouth disease virus despite replication in a constant environment J. Gen. Virol. 85 2004 2289 2297
75. C.M. Ruiz-Jarabo, N. Sevilla, M. Dávila, G. Gómez-Mariano, E. Baranowski, and E. Domingo Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif J. Gen. Virol. 80 1999 1899 1909
76. A.R. Samuel, and N.J. Knowles Foot-and-mouth disease virus: cause of the recent crisis for the UK livestock industry Trends Genet. 17 8 2001 421 424
77. K. Saunders, and A.M. King Guanidine-resistant mutants of aphthovirus induce the synthesis of an altered nonstructural polypeptide, P34 J. Virol. 42 2 1982 389 394
78. W.S. Severson, C.S. Schmaljohn, A. Javadian, and C.B. Jonsson Rivabirin causes error catastrophe during Hantaan virus replication J. Virol. 77 1 2003 481 488
79. N. Sevilla, and E. Domingo Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification J. Virol. 70 10 1996 6617 6624
80. N. Sevilla, N. Verdaguer, and E. Domingo Antigenically profound amino acid substitutions occur during large population passages of foot-and-mouth disease virus Virology 225 2 1996 400 405
81. Sierra, S., 2001. Caracterización de la respuesta del virus de la fiebre aftosa a mutagénesis química, Ph.D. Thesis. Universidad Autónoma de Madrid.
82. S. Sierra, M. Dávila, P.R. Lowenstein, and E. Domingo Response of foot-and-mouth disease virus to increased mutagenesis. Influence of viral load and fitness in loss of infectivity J. Virol. 74 2000 8316 8323
83. M.D. Sintchak, M.A. Fleming, O. Futer, S.A. Raybuck, S.P. Chambers, P.R. Caron, M.A. Murcko, and K.P. Wilson Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid Cell 85 6 1996 921 930
84. N.J. Snell Ribavirin - current status of a broad spectrum antiviral agent Expert Opin. Pharmacother. 2 8 2001 1317 1324
85. F. Sobrino, M. Dávila, J. Ortín, and E. Domingo Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture Virology 128 1983 310 318
86. F. Sobrino, and E. Domingo Foot-and-mouth disease in Europe EMBO Rep. 2 6 2001 459 461
87. D.G. Streeter, J.T. Witkowski, G.P. Khare, R.W. Sidwell, R.J. Bauer, R.K. Robins, and L.N. Simon Mechanism of action of 1-β-d-ribofuranosyl-1,2,4- triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent Proc. Natl. Acad. Sci. U.S.A. 70 4 1973 1174 1178
88. J. Swetina, and P. Schuster Self-replication with errors. A model for polynucleotide replication Biophys. Chem. 16 4 1982 329 345
89. J.P. Varma Inhibition of tobacco necrosis virus by guanidine carbonate Virology 36 2 1968 305 308
90. M.V. Volkenstein Physical Approaches to Biological Evolution 1994 Springer-Verlag Berlin, Germany
91. S.C. Weaver, A.C. Brault, W. Kang, and J.J. Holland Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells J. Virol. 73 5 1999 4316 4326
92. J.W. Weiss, and H.C. Pitot Alteration of ribosomal precursor RNA in Novikoff hepatoma cells by 5-azacytidine. Studies on methylation of 45S and 32S RNA Arch. Biochem. Biophys. 165 2 1974 588 596
93. K.C. Young, K.L. Lindsay, K.J. Lee, W.C. Liu, J.W. He, S.L. Milstein, and M.M. Lai Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy Hepatology 38 4 2003 869 878
94. H. Yu, R. Eritja, L.B. Bloom, and M.F. Goodman Ionization of bromouracil and fluorouracil stimulates base mispairing frequencies with guanine J. Biol. Chem. 268 21 1993 15935 15943